Common CFTR haplotypes and susceptibility to chronic pancreatitis and congenital bilateral absence of the vas deferens

Human Mutation

Volumn 32, Issue 8, 2011, Pages 912-920

  Steiner, Bernhard ^a   Rosendahl, Jonas ^b   Witt, Heiko ^c   Teich, Niels ^d   Keim, Volker ^b   Schulz, Hans Ulrich ^e   Pfützer, Roland ^f   Lühr, Matthias ^g   Gress, Thomas M ^h   Nickel, Renate ^c   Landt, Olfert ⁱ   Koudova, Monika ^j   Macek, Milan ^j   Farre, Antoni ^k   Casals, Teresa ^l   Desax, Marie Claire ^m   Gallati, Sabina ⁿ   Gomez Lira, Macarena ^o   Audrezet, Marie Pierre ^p   Férec, Claude ^p   Des Georges, Marie ^q,r,s   Claustres, Mireille ^q,r,s   Truninger, Kaspar ^t   more..

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Internistische Gemeinschaftspraxis f ur Verdauungs und Stoffwechselerkrankungen   (Germany)

^e OTTO VON GUERICKE UNIVERSITY   (Germany)

^f Division of Internal Medicine   (Germany)

^g KAROLINSKA INSTITUTE   (Sweden)

^h PHILIPPS UNIVERSITY MARBURG   (Germany)

ⁱ TIB MOLBIOL GmbH   (Germany)

^j UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^k HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^l BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^m KANTONSSPITAL   (Switzerland)

ⁿ UNIVERSITY OF BERN   (Switzerland)

^o UNIVERSITY OF VERONA   (Italy)

^p UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^q HÔPITAL ARNAUD DE VILLENEUVE   (France)

^r INSERM   (France)

^s UNIV MONTPELLIER   (France)

^t Spital Region Oberaargau   (Switzerland)

more..

Author keywords

CBAVD; CFTR; Idiopathic chronic pancreatitis

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; ARTICLE; CHRONIC PANCREATITIS; CONGENITAL BILATERAL ABSENCE OF THE VAS DEFEREN; CONTROLLED STUDY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT MALFORMATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CARRIER PROTEINS; CHILD; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPISTASIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INFERTILITY, MALE; MALE; MALE UROGENITAL DISEASES; MIDDLE AGED; MUTATION; PANCREATITIS, CHRONIC; VAS DEFERENS; YOUNG ADULT;

EID: 79960835880     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.21511     Document Type: Article

References (35)

1. Audrezet MP, Chen JM, Le Marechal C, Ruszniewski P, Robaszkiewicz M, Raguenes O, Quere I, Scotet V, Ferec C. 2002. Determination of the relative contribution of three genes-the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene-to the etiology of idiopathic chronic pancreatitis. Eur J Hum Genet 10:100-106.
2. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B57:289-300.
3. Cartegni L, Krainer AR. 2002. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet 30:377-384.
4. Casals T, Aparisi L, Martinez-Costa C, Gimenez J, Ramos MD, Mora J, Diaz J, Boadas J, Estivill X, Farre A. 2004. Different CFTR mutational spectrum in alcoholic and idiopathic chronic pancreatitis? Pancreas 28:374-379.
5. Chang MC, Chang YT, Wei SC, Tien YW, Liang PC, Jan IS, Su YN, Wong JM. 2007. Spectrum of mutations and variants/haplotypes of CFTR and genotype-phenotype correlation in idiopathic chronic pancreatitis and controls in Chinese by complete analysis. Clin Genet 71:530-539.
6. Chang YT, Chang MC, Su TC, Liang PC, Su YN, Kuo CH, Wei SC, Wong JM. 2008. Association of cystic fibrosis transmembrane conductance regulator (CFTR) mutation/variant/haplotype and tumor necrosis factor (TNF) promoter polymorphism in hyperlipidemic pancreatitis. Clin Chem 54:131-138.
7. Chillon M, Casals T, Mercier B, Bassas L, Lissens W, Silber S, Romey MC, Ruiz-Romero J, Verlingue C, Claustres M. 1995. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 332:1475-1480.
8. Claustres M. 2005. Molecular pathology of the CFTR locus in male infertility. Reprod Biomed Online 10:14-41.
9. Cordell HJ, Clayton DG. 2002. A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am J Hum Genet 70:124-141.
10. Cuppens H, Lin W, Jaspers M, Costes B, Teng H, Vankeerberghen A, Jorissen M, Droogmans G, Reynaert I, Goossens M, Nulius B, Cassiman JJ. 1998. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest 101:487-496.
11. Dahl M, Tybjaerg-Hansen A, Lange P, Nordestgaard BG. 1998. DeltaF508 heterozygosity in cystic fibrosis and susceptibility to asthma. Lancet 351:1911-1913.
12. De BK, Weren M, Proesmans M, Kerem E. 2005. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype. Pediatrics 115:e463-e469.
13. Excoffier L, Laval LG, Schneider S. 2005. Arlequin ver. 3.0: an integrated software package for population genetics data analysis. Evolut Bioinformatics Online 1:47-50.
14. Gavrilov DK, Shi X, Das K, Gilliam TC, Wang CH. 1998. Differential SMN2 expression associated with SMA severity. Nat Genet 20:230-231.
15. Gomez LM, Patuzzo C, Castellani C, Bovo P, Cavallini G, Mastella G, Pignatti PF. 2001. CFTR and cationic trypsinogen mutations in idiopathic pancreatitis and neonatal hypertrypsinemia. Pancreatology 1:538-542.
16. Groman JD, Hefferon TW, Casals T, Bassas L, Estivill X, Des GM, Guittard C, Koudova M, Fallin MD, Nemeth K, Fekete G, Kadasi L, Friedman K, Schwarz M, Bombieri C, Pignatti PF, Kanavakis E, Tzetis M, Schwartz M, Novelli G, D'Apice MR, Sobczynska-Tomaszewska A, Bal J, Stuhrmann M, Macek Jr M, Claustres M, Cutting GR. 2004. Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign. Am J Hum Genet 74:176-179.
17. Groman JD, Meyer ME, Wilmott RW, Zeitlin PL, Cutting GR. 2002. Variant cystic fibrosis phenotypes in the absence of CFTR mutations. N Engl J Med 347:401-407.
18. Guggino WB, Stanton BA. 2006. New insights into cystic fibrosis: molecular switches that regulate CFTR. Nat Rev Mol Cell Biol 7:426-436.
19. Hefferon TW, Groman JD, Yurk CE, Cutting GR. 2004. A variable dinucleotide repeat in the CFTR gene contributes to phenotype diversity by forming RNA secondary structures that alter splicing. Proc Natl Acad Sci USA 101:3504-3509.
20. Henckaerts L, Jaspers M, Van SW, Vliegen L, Fevery J, Nuytten H, Roskams T, Rutgeerts P, Cassiman JJ, Vermeire S, Cuppens H. 2009. Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitis. J Hepatol 50:150-157.
21. Ioannidis JP. 2007. Non-replication and inconsistency in the genome-wide association setting. Hum Hered 64:203-213.
22. Knowles MR, Durie PR. 2002. What is cystic fibrosis? N Engl J Med 347:439-442.
23. Lee JH, Choi JH, Namkung W, Hanrahan JW, Chang J, Song SY, Park SW, Kim DS, Yoon JH, Suh Y, Jang IJ, Nam JH, Kim SJ, Cho MO, Lee JE, Kim KH, Lee MG. 2003. A haplotype-based molecular analysis of CFTR mutations associated with respiratory and pancreatic diseases. Hum Mol Genet 12:2321-2332.
24. Mercier B, Verlingue C, Lissens W, Silber SJ, Novelli G, Bonduelle M, Audrezet MP, Ferec C. 1995. Is congenital bilateral absence of vas deferens a primary form of cystic fibrosis? Analyses of the CFTR gene in 67 patients. Am J Hum Genet 56:272-277.
25. Moskowitz SM, Chmiel JF, Sternen DL, Cheng E, Gibson RL, Marshall SG, Cutting GR. 2008. Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders. Genet Med 10:851-868.
26. Pignatti PF, Bombieri C, Marigo C, Benetazzo M, Luisetti M. 1995. Increased incidence of cystic fibrosis gene mutations in adults with disseminated bronchiectasis. Hum Mol Genet 4:635-639.
27. Sasieni PD. 1997. From genotypes to genes: doubling the sample size. Biometrics 53:1253-1261.
28. Stankovic M, Nikolic A, Divac A, Tomovic A, Petrovic-Stanojevic N, Andjelic M, Dopudja-Pantic V, Surlan M, Vujicic I, Ponomarev D, Mitic-Milikic M, Kusic J, Radojkovic D. 2008. The CFTR M470V gene variant as a potential modifier of COPD severity: study of Serbian population. Genet Test 12:357-362.
29. Steiner B, Truninger K, Sanz J, Schaller A, Gallati S. 2004. The role of common single-nucleotide polymorphisms on exon 9 and exon 12 skipping in nonmutated CFTR alleles. Hum Mutat 24:120-129.
30. Stephens M, Donnelly P. 2003. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162-1169.
31. Stephens M, Smith NJ, Donnelly P. 2001. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68:978-989.
32. Truninger K, Malik N, Ammann RW, Muellhaupt B, Seifert B, Muller HJ, Blum HE. 2001. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. Am J Gastroenterol 96:2657-2661.
33. Tzetis M, Efthymiadou A, Strofalis S, Psychou P, Dimakou A, Pouliou E, Doudounakis S, Kanavakis E. 2001. CFTR gene mutations-including three novel nucleotide substitutions-and haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease. Hum Genet 108:216-221.
34. Wang X, Kim J, McWilliams R, Cutting GR. 2005. Increased prevalence of chronic rhinosinusitis in carriers of a cystic fibrosis mutation. Arch Otolaryngol Head Neck Surg 131:237-240.
35. Witt H, Luck W, Hennies HC, Classen M, Kage A, Lass U, Landt O, Becker M. 2000. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 25:213-216.